Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and...
Transcript of Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and...
![Page 1: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/1.jpg)
Advances in Interstitial lung
disease - New disease
perspectives
Chai Gin Tsen
Dept of Respiratory and Critical Care Medicine
![Page 2: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/2.jpg)
![Page 3: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/3.jpg)
Scope
• Introduction
• Classification of interstitial lung disease (ILD)/diffuse lung disease
• Idiopathic pulmonary fibrosis (IPF) – diagnosis and treatment
• Issues with ILD guidelines
• Disease behaviour classification
• Case studies
• Summary
![Page 4: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/4.jpg)
Scope
• We are not going to talk about specific ILD
entities
• Introduce a different way to approach this group
of complicated disease entities
![Page 5: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/5.jpg)
Introduction
• Please forget about these terms:
– Pulmonary fibrosis
– Fibrosing alveolitis
• Group of disease that affects the lung
parenchyma diffusely, which includes PCP,
miliary TB, lymphangitis carcinomatosis or
ARDS
• Not all ILDs have fibrosis
• Instead use the phrase interstitial lung disease
(ILD) or diffuse lung disease
![Page 6: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/6.jpg)
![Page 7: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/7.jpg)
Old classification - 2002
AJRCCM 2002
![Page 8: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/8.jpg)
Old classification - 2002
AJRCCM 2002
![Page 9: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/9.jpg)
Travis W et al. AJRCCM 2013
Revised criteria 2013
![Page 10: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/10.jpg)
Idiopathic interstitial pneumonia
(IIP) • The key issue is to differentiate idiopathic
pulmonary fibrosis (IPF) from the rest
• Diagnosis is prognosis
C Ryerson ERJ 2013
![Page 11: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/11.jpg)
Idiopathic Pulmonary Fibrosis
(IPF)
![Page 12: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/12.jpg)
Changes in IPF diagnosis over
the years 1999 ATS guidelines
All major + 3 out of 4 minor (No SLBx)
2011 ATS guidelines
![Page 13: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/13.jpg)
HRCT features – usual
interstitial pneumonia (UIP)
![Page 14: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/14.jpg)
2011 ATS/ERS/JRS/ALAT IPF guidelines
![Page 15: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/15.jpg)
2011 ATS/ERS/JRS/ALAT IPF guidelines
![Page 16: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/16.jpg)
IPF Treatment 1999 ATS IPF guidelines 2011 ATS/ERS/JRS/ALAT IPF guidelines
![Page 17: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/17.jpg)
2012: In comes the PANTHER
Combination of prednisolone + azathioprine + NAC
vs
placebo
Raghu G et al. NEJM 2012
![Page 18: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/18.jpg)
CAPACITY
P Noble et al. Lancet 2011
ASCEND
King TE et al. NEJM 2014
A New Hope: Pirfenidone vs
placebo trials
![Page 19: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/19.jpg)
IMPULSIS: Nintedanib vs
placebo
Richeldi L et al. NEJM 2014
![Page 20: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/20.jpg)
2015 ATS/ERS/JRS/ALAT updated IPF guidelines
![Page 21: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/21.jpg)
Diagnosis of ILD
![Page 22: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/22.jpg)
How do we diagnose and
manage ILD in 2016?
A. HRCT provides “truth data”. Other clinical information has no role
B. Biopsy all patients: therein lies the truth. Clinical reasoning has no role
C. View all IIP as essentially the same disorder and treat with steroids
D. Apply guidelines and treat according to recommendations
E. I disagree with all of the above
![Page 23: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/23.jpg)
Traditional approach
![Page 24: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/24.jpg)
Why traditional guidelines fail in
ILD? 1. Unlike medical oncology or pulmonary
hypertension, there is no gold standard in
diagnosing many ILDs
2. Up to 5-15% of ILDs are “unclassifiable” even
in expert centres. (CJ Ryerson et al. ERJ
2013; Skolnik K et al. Respirology 2015)
3. Confusing terminology
![Page 25: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/25.jpg)
Walsh S et al. Lancet Respir Med 2016
Pathological dx of IPF is not the
gold standard
![Page 26: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/26.jpg)
Issues with sampling
![Page 27: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/27.jpg)
Too many patients fall outside the
trials and guidelines!
377 patients with working dx of IPF in Edinburgh:
- 77% excluded for CAPACITY
- 92% excluded for ASCEND
- 71% excluded for PANTHER
Lisa Nicol et al. ERS 2015 abstract
![Page 28: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/28.jpg)
Confusing terminologies
Obliterative bronchiolitis, proliferative
bronchiolitis, constrictive bronchiolitis,
bronchiolitis obliterans organizing pneumonia,
cellular bronchiolitis, lymphocytic bronchiolitis,
diffuse panbronchiolitis, respiratory
bronchiolitis, cryptogenic constrictive
bronchiolitis, airway centered interstitial fibrosis
![Page 29: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/29.jpg)
A different question is needed
• Historically, the primary question has been
“what is the diagnosis”?
• Pragmatically, the primary question should be
“what are you going to do about it”?
![Page 30: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/30.jpg)
A metaphor for diagnostic
practice
Warp = the basic ILD knowledge
Weft = everything that is individual in patients including disease behavior
Integrate into a multi disciplinary discussion
![Page 31: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/31.jpg)
The “warp” – basic ILD knowledge
• Complete history, physical examination, age, co-
morbidities, smoking history, reflux, CTD history,
family history
• Precipitating causes: occupational, drugs,
environmental exposures
• Severity of disease – lung function, 6MWT
• HRCT
• Other investigations: echocardiogram,
autoimmune markers, bronchoscopy, surgical
lung biopsy
![Page 32: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/32.jpg)
The weft - “disease behaviour”
• How does the disease progress over a period of
time?
• Is it acute? Is it stable over many years? Are
there intermittent exacerbations?
• How does it respond to previous treatments e.g.
steroid responsiveness?
• Subjective assessment: Symptoms
• Objective assessments: Lung function tests,
HRCT pattern (is it predominantly ground glass,
fibrotic) and their trend
![Page 33: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/33.jpg)
Reversible, self limiting or
irreversible, stable:
Do we need to treat it? e.g. smoking related ILDs, mild
drug induced ILD
Can the disease be
reversed? Reversible with risk of
progression e.g. NSIP, OP
Can the disease be
stabilized? Reversible with potential to
stabilize e.g. some fibrotic NSIP
Irreversible and progressive:
How do we slow it down? e.g. IPF, some fibrotic HP, NSIP
Yes
Yes
MICO (masterly inactivity
with cat-like observation)
Yes
Yes
No
No
No
Treat high to achieve
response e.g. IV methylpred,
long term maintenance to
preserve gains.
Treat to maintain stability
Anti-fibrotics in selected
patients, consider effective
palliation, lung transplant
![Page 34: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/34.jpg)
Travis W et al. AJRCCM 2013
![Page 35: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/35.jpg)
Integrate into a multi
disciplinary meeting (MDM)
![Page 36: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/36.jpg)
Jo et al. BMC Pulmonary
Medicine 2016
Components of MDM
![Page 37: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/37.jpg)
Some case examples to
illustrate how it works
![Page 38: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/38.jpg)
Case 1
• 71 year old man, ex-smoker
• Breathlessness for 3 years but progressively
worse last 1 year
• Given trial of steroids for 6 months without any
improvement
• No CTD symptoms
• No other exposures
![Page 39: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/39.jpg)
![Page 40: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/40.jpg)
Lung function
FVC DLCO
Sep 2013 1.45L (62%) 3.8 (65%)
May 2014 1.21L 2.8 (50%)
May 2015
1.1L 2.1 (36%)
May 2016 0.94L (47%) Not done as
FVC < 1L
![Page 41: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/41.jpg)
G Raghu et al. AJRCCM
2010
![Page 42: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/42.jpg)
What would you do?
A. Send for surgical lung biopsy since the
guideline says so
B. Treat as unclassifiable ILD as patient is
too high risk for a lung biopsy due to
poor lung function
C. Do bronchoscopy and TBLB
D. Treat as IPF and consider anti-fibrotics,
effective palliation and lung transplant
![Page 43: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/43.jpg)
Can we diagnose IPF in patients without
honeycombing on HRCT in the absence of a
surgical lung bx?
CD Fell et al. AJRCCM 2010
71 year old
Diffuse lung fibrosis
![Page 44: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/44.jpg)
Reversible, self limiting or
irreversible, stable:
Do we need to treat it? e.g. smoking related ILDs, mild
drug induced ILD
Can the disease be
reversed? Reversible with risk of
progression e.g. NSIP, OP
Can the disease be
stabilized? Reversible with potential to
stabilize e.g. some fibrotic NSIP
Irreversible and progressive:
How do we slow it down? e.g. IPF, some fibrotic HP, NSIP
Yes
Yes
MICO (masterly inactivity
with cat-like observation)
Yes
Yes
No
No
No
Treat high to achieve
response e.g. IV methylpred,
long term maintenance to
preserve gains.
Treat to maintain stability
Anti-fibrotics in selected
patients, consider effective
palliation, lung transplant
![Page 45: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/45.jpg)
Case 1
• Clinical history fits
• Disease behaving like IPF
• MDM discussion and manage as per IPF
algorithm
![Page 46: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/46.jpg)
Case 2
• 57 year old lady, non-smoker
• Worsening breathlessness over 4-5 months
• Hx of hypertension, hyperlipidemia, bilat ovarian cysts and fibroids s/p THBSO
• Treated as pneumonia with antibiotics without any improvement
• Mechanic’s hand, fine crackles at lung bases
![Page 47: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/47.jpg)
![Page 48: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/48.jpg)
Case 2
• CK normal
• ANA negative
• Other autoimmune markers pending
• FVC 1.15L (47%), DLCO 2.9 (47%)
![Page 49: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/49.jpg)
What will you do?
A. Observe, wait for autoimmune markers
and repeat a CXR and lung function test
in 3 month’s time
B. Oral prednisolone at 0.5mg/kg/day
C. IV methylprednisolone 15mg/kg/day x 3
days followed by IV cyclophosphamide
D. Start Pirfenidone
![Page 50: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/50.jpg)
The “weft” and “warp”
• Female, mechanic’s hands, NSIP pattern
on CT with no evidence of fibrosis… yet
• Fairly rapid progression
• Severe impairment in lung function - FVC
47% predicted
![Page 51: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/51.jpg)
Reversible, self limiting or
irreversible, stable:
Do we need to treat it? e.g. smoking related ILDs, mild
drug induced ILD
Can the disease be
reversed? Reversible with risk of
progression e.g. NSIP, OP
Can the disease be
stabilized? Reversible with potential to
stabilize e.g. some fibrotic NSIP
Irreversible and progressive:
How do we slow it down? e.g. IPF, some fibrotic HP, NSIP
Yes
Yes
MICO (masterly inactivity
with cat-like observation)
Yes
Yes
No
No
No
Treat high to achieve
response e.g. IV methylpred,
long term maintenance to
preserve gains.
Treat to maintain stability
Anti-fibrotics in selected
patients, consider effective
palliation, lung transplant
![Page 52: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/52.jpg)
What we did
• IV hydrocortisone, converted to tapering doses of oral prednisolone 1mg/kg/day
• IV cyclophosphamide
• Further blood results: anti Jo1 positive
• After 3# of IV cyclophosphamide
– FVC 1.15L 1.61L (66%)
• To complete total 6# of IV cyclo and transition to azathioprine and prednisolone to maintain gains
![Page 53: Chai Gin Tsen Dept of Respiratory and Critical Care Medicine Chai Gin Tsen Dept of Respiratory and Critical Care Medicine . Scope •Introduction •Classification of interstitial](https://reader033.fdocuments.net/reader033/viewer/2022060518/604c44601383011eea0d66e5/html5/thumbnails/53.jpg)
Summary
• IPF diagnosis = prognosis
• ILD diagnosis: biopsy does not provide truth data
• MDM is essential for diagnosis of ILDs
• Integration of clinical reasoning, morphologic (CT and pathology) pattern recognition, examined against the disease behaviour will help guide management even in unclassifiable cases